When do biologic drug patents expire and when will biosimilars launch?

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Baxalta Us Inc.	GAMMAGARD, GAMMAGARD S/D, IVEEGAM	immune globulin intravenous (human)	For Injection	103133	02/18/1986	⤷ Try a Trial	2024-12-18
Baxalta Us Inc.	GAMMAGARD, GAMMAGARD S/D, IVEEGAM	immune globulin intravenous (human)	For Injection	103133	07/27/2000	⤷ Try a Trial	2024-12-18
Immunex Corporation	ENBREL	etanercept	For Injection	103795	11/02/1998	⤷ Try a Trial	2024-12-18
Immunex Corporation	ENBREL	etanercept	For Injection	103795	05/27/1999	⤷ Try a Trial	2024-12-18
Immunex Corporation	ENBREL	etanercept	Injection	103795	09/27/2004	⤷ Try a Trial	2024-12-18
Immunex Corporation	ENBREL	etanercept	Injection	103795	02/01/2007	⤷ Try a Trial	2024-12-18
Immunex Corporation	ENBREL MINI	etanercept	Injection	103795	09/14/2017	⤷ Try a Trial	2024-12-18
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Title:	Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
Abstract:	A method for delivering a biologic to a human, comprising administering said biologic parenterally into the perispinal space of said human without direct intrathecal injection and positioning said human in a Trendelenburg position.
Inventor(s):	Tobinick; Edward Lewis (Santa Monica, CA)
Assignee:
Application Number:	12/568,661
Patent Claims:	1. A method for delivering a biologic to a human, comprising: administering said biologic parenterally into the perispinal space of said human without direct intrathecal or epidural injection and then positioning said human in a Trendelenburg position. 2. The method of claim 1, wherein said biologic is etanercept. 3. The method of claim 1, wherein said biologic is golimumab. 4. The method of claim 1, wherein said biologic is Gammagard. 5. The method of claim 1, wherein said biologic is bapineuzumab. 6. The method of claim 1, wherein said human has neck pain. 7. The method of claim 1, wherein said human has cervical radiculopathy. 8. The method of claim 1, wherein said human has degenerative disc disease. 9. The method of claim 1, wherein said human has fibromyalgia. 10. The method of claim 1, wherein said human has neuropathic pain. 11. The method of claim 1, wherein said human has sciatica. 12. The method of claim 1, wherein said human has low back pain.

Claims for Patent: 8,236,306